G.R. No. 169304 - Department of Health vs. Phil. Pharmawealth, Inc.

Case Summary (G.R. No. 169304)

Key Dates

Relevant administrative issuances and actions: Administrative Order (A.O.) No. 27 (Dec. 22, 1998); A.O. No. 10 (Series of 2000) amending accreditation procedures; Phil. Pharmawealth submissions for accreditation of additional products, including Penicillin G Benzathine (May 9 and May 29, 2000); DOH Invitation for Bids and bid opening (September–October 2000, bid opening Oct. 11, 2000). Procedural history: RTC Order denying motion to dismiss (Dec. 8, 2003); CA Decision affirming RTC (May 12, 2005) and CA Resolution denying reconsideration (Aug. 9, 2005); Supreme Court decision resolving the petition (March 13, 2007). Applicable constitutional basis: 1987 Constitution.

Applicable Law and Precedents

Primary constitutional and procedural authorities relied upon in the decision: Section 1, Article VIII (judicial review) and Section 3, Article XVI (state immunity) of the 1987 Constitution; Section 1, Rule 58 of the Rules of Court (definition and scope of preliminary injunction). Notable judicial precedents cited: Philippine Agila Satellite, Inc. v. Trinidad‑Lichauco; Shauf v. Court of Appeals (and related authorities such as United States of America v. Reyes); Director of the Bureau of Telecommunications v. Aligaen; Lansang v. Court of Appeals; Festejo v. Fernando; Sanders v. Veridiano II. These authorities frame the principles on suability of the State and its officers, the availability of judicial review for acts tainted with grave abuse of discretion, and the exceptions to sovereign immunity where officials act beyond or contrary to legal authority.

Facts Relevant to the Dispute

A.O. No. 10 (Series of 2000) required that only products accredited by the DOH Committee be procured by the DOH. Phil. Pharmawealth submitted requests to include additional accredited products, among them Penicillin G Benzathine, in May 2000. DOH’s schedule indicated that processing of such requests would result in release by September 2000. In September 2000 the DOH issued an Invitation for Bids for 1.2 million vials of Penicillin G Benzathine. Despite receiving no final DOH response on its accreditation request, Phil. Pharmawealth nonetheless submitted a bid. At bid opening (Oct. 11, 2000) Phil. Pharmawealth was the lowest bidder (P82.24 per unit) compared with YSS (P95.00 per unit). Because Pharmawealth’s Penicillin G Benzathine product remained non‑accredited, DOH awarded the contract to YSS.

Trial Court and Court of Appeals Proceedings

Phil. Pharmawealth filed suit in the RTC seeking injunction, mandamus and damages, and prayed for nullification of the award to YSS and declaration that Pharmawealth was the lowest complying responsible bidder, among other reliefs. Petitioners (DOH and individual officials) moved to dismiss on grounds including state immunity and lack of authorization of Pharmawealth’s representative, arguing broad governmental discretion in accepting or rejecting bids. The RTC denied the motion to dismiss (Dec. 8, 2003). The CA, in CA‑G.R. SP No. 84457, affirmed the RTC in a decision dated May 12, 2005 and denied petitioners’ motion for reconsideration (Aug. 9, 2005). The petition to the Supreme Court challenged only whether the CA erred in upholding the denial of the motion to dismiss.

Legal Issue Presented

Whether the Court of Appeals erred in affirming the RTC’s denial of petitioners’ motion to dismiss by applying the doctrine of state immunity and determining whether DOH and the individual DOH officials were suable in the capacities in which they were impleaded.

Court’s Analysis on Suability and State Immunity

The Court reaffirmed that suability depends on (1) whether the official acted within official/jurisdictional capacity and (2) whether the relief sought would impose a charge or financial liability against the State. The Constitution guarantees judicial review (Section 1, Article VIII), and where acts are alleged to be tainted with grave abuse of discretion, judicial review is available and the official should be impleaded in their official capacity. Preliminary injunctions and mandamus — the principal non‑monetary remedies sought by Phil. Pharmawealth — may be directed against agencies and do not necessarily seek to impose a financial charge upon the State; thus, the defense of state immunity from suit does not bar such ca

Case Syllabus (G.R. No. 169304)

Procedural History

Petition for review filed from Court of Appeals decisions in CA-G.R. SP No. 84457: Decision dated May 12, 2005 affirming the trial court's denial of petitioners' motion to dismiss Civil Case No. 68208; and Resolution dated August 9, 2005 denying petitioners' motion for reconsideration.
Respondent’s original complaint for injunction, mandamus and damages with prayer for preliminary injunction/temporary restraining order filed with the Regional Trial Court (RTC) of Pasig City seeking nullification of award of the Penicillin G Benzathine contract and damages against DOH officials.
Petitioners filed a manifestion and motion to dismiss (invoking state immunity) which the RTC denied by Order of December 8, 2003; motion for reconsideration denied March 15, 2004.
Petitioners elevated the matter to the Court of Appeals by petition for certiorari; CA affirmed the RTC Order by Decision dated May 12, 2005 and denied reconsideration by Resolution dated August 9, 2005.
Petitioners filed the instant petition for review with the Supreme Court raising a single issue: whether the Court of Appeals erred in upholding denial of the motion to dismiss.

Factual Background

Respondent Phil. Pharmawealth, Inc. is a domestic corporation manufacturing and supplying pharmaceutical products to government hospitals.
On May 9, 2000 and May 29, 2000, respondent submitted requests to the Department of Health (DOH) for inclusion of additional items in its list of accredited drug products, including Penicillin G Benzathine.
DOH’s processing schedule indicated results of respondent’s requests were due by September 2000 (the last month of the quarter following filing).
In September 2000, DOH, through Undersecretary Antonio M. Lopez (chairperson of the pre-qualification, bids and awards committee), issued an Invitation for Bids for procurement of 1.2 million vials of Penicillin G Benzathine.
Despite no response from DOH regarding accreditation of respondent’s product, respondent submitted a bid for the Penicillin G Benzathine contract.
Bids opened on October 11, 2000: respondent submitted the lower bid of P82.24 per unit; Cathay/YSS Laboratories (YSS) bid P95.00 per unit.
Because respondent’s Penicillin G Benzathine product was not accredited, DOH awarded the contract to YSS.
Respondent alleged grave abuse of discretion and bad faith in the non-award and sought injunctive and mandamus relief and damages.

Relevant Administrative Orders and Guidelines

Administrative Order (A.O.) No. 27, Series of 1998 (issued December 22, 1998 by Secretary Alberto G. Romualdez, Jr.) set guidelines and procedures for accreditation of government suppliers for pharmaceutical products.
A.O. No. 10, Series of 2000 amended A.O. No. 27 to provide additional guidelines for accreditation aimed to ensure only qualified bidders transact business with the DOH.
Part V of A.O. No. 10 contains provisions (quoted in the source):
- Drug Manufacturer, Drug Trader and Drug Importer shall be allowed to apply for accreditation.
- Accreditation shall be done by the Central Office-Department of Health.
- A separate accreditation is required for the drug suppliers and for their specific products.
- Only products accredited by the Committee shall be allowed to be procured by the DOH and all other entities under its jurisdiction.
The DOH’s schedule indicated the processing timeline for accreditation requests (Memorandum No. 125-A, s. 2000).

Events Leading to the Dispute

Respondent’s accreditation request that included Penicillin G Benzathine was filed in May 2000 but had not been acted upon by DOH by the time DOH issued the Invitation for Bids in September 2000.
Respondent, despite lack of accreditation confirmation, bid and was lowest bidder.
DOH awarded the contract to YSS on the ground that respondent’s specific product was not accredited as required by A.O. No. 10.
Respondent challenged the award and sought judicial relief including nullification of the award, declaration as lowest complying responsible bidder, mandatory award to respondent, and damages against DOH and individual DOH officials.

Trial Court Proceedings and Orders

Respondent filed Complaint for Injunction, Mandamus and Damages in RTC Pasig, Civil Case No. 68208.
Petitioners (DOH and individual officials) filed Comment arguing DOH’s reservation to accept or reject any or all bids without liability and asserting government agencies’ discretion; later filed a Manifestation and Motion to Dismiss invoking state immunity and arguing lack of authorization of respondent’s representative to file suit.
Respondent opposed the motion to dismiss, arguing state immunity inapplicable because individual petitioners were sued in both official and personal capacities.
RTC denied petitioners’ motion to dismiss by Order dated December 8, 2003.
Petitioners’ motion for reconsideration before RTC was denied by Order dated March 15, 2004.

Court of Appeals Proceedings

Petitioners filed a petition for certiorari with the Court of Appeals contesting the RTC denial of the motion to dismiss.
Court of Appeals, in CA rollo pp. 186-197 (Decision penned by Associate Justice Monina Arevalo-Zenarosa, concurred in by Justices Remedios A. Salazar-Fernando and Rosmari D. Carandang), affirmed the RTC Order by Decision dated May 12, 2005.
Court of Appeals denied petitioners’ motion for reconsideration by Resolution dated August 9, 2005.
The issues regarding suability and application of state immunity were reviewed and left for the Supreme